Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells by Trapp, Simon et al.
J Cell Mol Med. 2021;00:1–13.    |  1wileyonlinelibrary.com/journal/jcmm
 
Received: 1 November 2020  |  Revised: 9 February 2021  |  Accepted: 11 February 2021
DOI: 10.1111/jcmm.16404  
O R I G I N A L  A R T I C L E
Pancreatitis severity in mice with impaired CFTR function but 
pancreatic sufficiency is mediated via ductal and inflammatory 
cells- Not acinar cells
Simon Trapp1 |   Ali A. Aghdassi1  |   Juliane Glaubitz1 |   Matthias Sendler1 |    
Frank Ulrich Weiss1 |   Jens Peter Kühn2 |   Marie- Luise Kromrey2 |   Ujjwal M. Mahajan1,3 |   
Petra Pallagi4 |   Zoltán Rakonczay Jr5 |   Viktória Venglovecz6 |   Markus M. Lerch1 |   
Peter Hegyi7 |   Julia Mayerle1,3
1Department of Medicine A, University Medicine Greifswald, Greifswald, Germany
2Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
3Department of Medicine II, Ludwig- Maximilians University Munich, Munich, Germany
4First Department of Medicine, University of Szeged, Szeged, Hungary
5Department of Pathophysiology, University of Szeged, Szeged, Hungary
6Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary
7Department of Translational Medicine/First Department of Medicine, Medical School, Institute for Translational Medicine, Pécs, Hungary
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Correspondence
Markus M. Lerch, Department of Medicine 





Award Number: AG 203/2- 1/4- 1, MA 
4115/1- 2/3, SE 2702/2- 1 and GRK 1947;A3; 
Federal Ministry of Education and Research, 
Grant/Award Number: 03IS2061A, 
0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, 
03ZIK012, 03zz0921E and 03ZZ0921E; 
European Union, Grant/Award Number: 
V- 630- S- 150- 2012/132/133; PePPP centre 
of excellence MV, Grant/Award Number: 
ESF/14- BM- A55- 0045/16; EnErGie/P2 
Project, Grant/Award Number: ESF/14- BM- 
A55- 0008/18; Open access funding enabled 
and organized by projektDEAL.
Abstract
Mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) 
are an established risk factor for cystic fibrosis (CF) and chronic pancreatitis. Whereas 
patients with CF usually develop complete exocrine pancreatic insufficiency, pancre-
atitis patients with CFTR mutations have mostly preserved exocrine pancreatic func-
tion. We therefore used a strain of transgenic mice with significant residual CFTR 
function (CFTRtm1HGU) to induce pancreatitis experimentally by serial caerulein injec-
tions. Protease activation and necrosis were investigated in isolated acini, disease 
severity over 24h, pancreatic function by MRI, isolated duct stimulation and faecal 
chymotrypsin, and leucocyte function by ex vivo lipopolysaccharide (LPS) stimula-
tion. Pancreatic and lung injury were more severe in CFTRtm1HGU but intrapancreatic 
trypsin and serum enzyme activities higher than in wild- type controls only at 8h, a 
time interval previously attributed to leucocyte infiltration. CCK- induced trypsin ac-
tivation and necrosis in acini from CFTRtm1HGU did not differ from controls. Fluid and 
bicarbonate secretion were greatly impaired, whereas faecal chymotrypsin remained 
unchanged. LPS stimulation of splenocytes from CFTRtm1HGU resulted in increased 
INF- γ and IL- 6, but decreased IL- 10 secretion. CFTR mutations that preserve residual 
pancreatic function significantly increase the severity of experimental pancreatitis— 
mostly via impairing duct cell function and a shift towards a pro- inflammatory pheno-
type, not by rendering acinar cells more susceptible to pathological stimuli.
2  |     TRAPP eT Al.
1  | INTRODUC TION
Pancreatitis is a common disease, often leading to hospital admis-
sion 1 and its underlying genetic susceptibilities are increasingly rec-
ognized,2 particularly in patients with chronic or relapsing forms of 
pancreatitis. Although most pathophysiological studies have focused 
on acinar cells or acinar cell- specific events such as a pathological 
secretagogue response,3 the balance between digestive protease 
activation and degradation via secretory4 or lysosomal enzymes,5- 8 
and the role of acinar cells as the initial site of injury,9 the role of 
other cell types such as duct cells10,11 and immune cells12- 14 has only 
recently become apparent. The cystic fibrosis transmembrane con-
ductance regulator (CFTR) is an ABC transporter- class ion channel 
protein that conducts chloride ions across epithelial cell membranes. 
Loss- of- function mutations in the CFTR gene were originally discov-
ered to be associated with cystic fibrosis (CF) in affected patients15 
and later found to play a role in male vas deference infertility and 
chronic pancreatitis. The latter association was initially detected 
using the original CF- mutation panels,16,17 subsequently character-
ized by full exome sequencing, and found to increase the susceptibil-
ity for pancreatitis around 2.5- fold to threefold.18,19 It later became 
obvious that, unlike in CF, mainly patients with exocrine pancreatic 
sufficiency and carriers of CFTR mutations with maintained residual 
CFTR function develop pancreatitis.20 The question whether and 
why only some carriers of the more than 1700 known CFTR mu-
tations (around 15% of the population in Western countries carry 
CFTR mutations) develop pancreatitis, and which cell types known to 
contribute to the disease pathogenesis are predominantly affected 
by CFTR impairment, is still under debate.21 It is further complicated 
by the fact that not only the type of mutation,22 but also a number 
of pleotropic and modifier effects23 appear to determine the manner 
and severity by which the pancreas is involved. Elegant experimen-
tal studies that were undertaken to elucidate the underlying mech-
anism of CFTR mutation- associated pancreatic damage have either 
used mice with a deleted cftr- gene (null mice) and thus no residual 
function 24 or with transgenically expressed cftr- deletion mutations 
also causing absence of cftr activity.25,26 To experimentally recreate 
a situation closer to the human geno- and phenotype, we have stud-
ied experimental pancreatitis in a mouse strain (CFTRtm1HGU) with 
significant residual CFTR function and no spontaneous pancreatic 
phenotype before adulthood.27 Pancreatic enzyme output in these 
mice was found to be unimpaired, but ductal bicarbonate and fluid 
secretion were strongly reduced. The severity of the disease was 
significantly increased, whereas the response and injury of isolated 
acinar cell remained unaffected. In vitro inflammatory cells from 
CFTRtm1HGU mice were found to respond to lipopolysaccharide (LPS) 
with an increased release of pro- inflammatory, and a decreased re-
lease of anti- inflammatory cytokines. These data indicate that “mild” 
CFTR mutations with significant residual exocrine pancreatic func-
tion increase the susceptibility towards pancreatitis, as well as the 
disease severity. This occurs independently of acinar cell events, but 
is due to an impairment of CFTR function in pancreatic duct cells and 
the immune system.
2  | MATERIAL S AND METHODS
2.1 | Materials
Caerulein, the biologically active, phosphorylated cholecystokinin 
(CCK) octapeptide (Tyr(SO 3 H)27)- cholecystokinin fragment) and 
amiloride were obtained from Sigma- Aldrich (Eppelheim, Germany), 
collagenase (Clostridium histolyticum, EC.3.4.24.3) from SERVA 
(lot no. 14007), human myeloperoxidase (MPO) from Calbiochem, 
the substrates R110- (Ile- Pro- Arg) and R110- (Ala)4 from Invitrogen, 
CBA mouse inflammation kit from Becton Dickinson, ‘Amyl’ amyl-
ase quantification kit and ‘Lip’ lipase quantification kit from Roche 
(Grenzach- Whylen), forskolin from Tocris Cookson and H2DIDS 
from Invitrogen Corporation. All other chemicals were of highest 
purity and obtained either from Sigma- Aldrich, Merck, Amersham 
Pharmacia Biotech or Bio- Rad.
2.2 | Induction of acute pancreatitis in wild- 
type and CFTR transgenic mice
All animal experiments were carried out after prior approval by 
the institutional animal care committee. CFTRtm1HGU mice were 
originally generated by Dorin et al28 and kindly provided by the col-
leagues B. Tümmler and U. Seidler from the Medical University of 
Hannover (MHH). By using an insertional vector that encompasses 
a part of intron 9 and extends into exon 10 (Figure 1A), the CFTR 
gene is disrupted and offspring of heterozygous mice were crossed 
leading to a phenotype with an impaired chloride ion transport but 
significant residual CFTR function of over 20% because the gene 
disruption by insertion does not result in the loss of any genomic 
sequence and the mutation is ‘leaky’ allowing for aberrant splicing 
of significant wild- type cftr mRNA.27 These mice have no spontane-
ous pancreatic phenotype and good long- term survival.29 Wild- type 
littermates were used as controls. All animals were maintained ac-
cording to institutional guidelines and protocols of the local animal 
facility and approved by the institutional animal care and use com-
mittee. For this study, 14- week- old male animals were used. Mice 
were starved overnight with access to water ad libitum. Acute pan-
creatitis was induced by 8 hourly intraperitoneal injections of CCK/
caerulein (50 µg/kg bodyweight) as previously reported.30
K E Y W O R D S
acute pancreatitis, CFTR, ductal cells, inflammatory cells
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2.3 | Preparation of serum and tissue samples
After kill, serum was aliquoted, snap- frozen and stored at −20°C for 
further analysis. Pancreatic tissue was partitioned and either frozen 
in liquid nitrogen and stored at −80°C for later enzymatic measure-
ments, fixed in 5% paraformaldehyde for paraffin embedding, or put 
into Cryomold ® embedding folds (Tissue Tek, Sakura Finetek) and 
snap- frozen. Parts of tissue used later for enzymatic assays were ho-
mogenized on ice in a buffer consisting of 100 mmol/L Tris, 5 mmol/L 
CaCl2 and pH 8.0.
2.4 | Preparation of pancreatic acinar cells
Acinar cells were prepared by collagenase digestion and isolated as 
previously described.4,31 Cells were maintained in Dulbecco's modi-
fied Eagle medium containing 2% bovine serum albumin (BSA) and 
10 mmol/L 4- (2- hydroxyethyl)- 1- piperazine ethanesulphonic acid 
(HEPES) and stimulated with 1 μmol/L CCK. Intracellular elastase activ-
ity was measured for up to 1 hour using the substrate R110- CBZ- (Ala)4 
in a fluorescence plate reader (BMG Labtech, Ortenberg, Germany). 
Cellular necrosis was measured by propidium iodine exclusion.32 All 
measurements were done in triplicates in a 96- well microtitre plate.
2.5 | Isolation of pancreatic ducts
Pancreatic ducts were isolated using a protocol as described pre-
viously.33 Intra- and interlobular ducts were isolated by enzymatic 
digestion and microdissection. Isolated ducts were incubated over-
night. During the overnight incubation, the ends of the ducts seal 
and begin to swell due to fluid secretion of the ductal cells.
2.6 | Isolation of splenocytes
Leucocytes were isolated from spleens of CFTRtm1HGU and wild- type 
mice using a 70- µm nylon cell filter (BD Falcon) to remove aggregates 
and cell debris.34 Erythrocytes were lysed by a solution contain-
ing 155 mmol/L NH4Cl, 10 mmol/L KHCO3 and 0.1 mmol/L EDTA. 
Neutrophil granulocytes were isolated from total leucocytes using a 
MACS® cell separation kit according to the manufacturer's instruction 
(Miltenyi Biotech, Bergisch- Gladbach, Germany).35,36 For separation of 
neutrophils, Ly6g served as a specific antibody. Both splenocytes and 
neutrophil granulocytes were counted in a Neubauer chamber and 
transferred to sterile PBS.
2.7 | Biochemical assays
Activity of serum lipase and amylase was measured by photometric 
absorbance assays (Roche Hitachi, Grenzach- Whylen, Germany) as 
kinetics over 30 min with an absorbance at 570 nm at 37°C. Purified 
enzymes (Sigma) were used for standardization. Trypsin activity in 
pancreatic homogenates was measured fluorometrically at 37°C 
for 1 hour using the substrate R110- CBZ- Ile- Pro- Arg (Invitrogen, 
Karlsruhe, Germany). Protein amount was quantified using the 
Bradford assay. To determine exocrine enzyme secretion, we 
measured chymotrypsin activity in stool as previously reported.37 
Briefly, stool was collected, stored at −20°C and later samples of 
15- 30 mg suspended in solvent (0.1% Triton X- 100, 0.5 M NaCl and 
100 mmol/L CaCl2), briefly sonicated and centrifuged at 20,000 
r.p.m. for 10 minutes at 0°C. Chymotrypsin activity was determined 
flurometrically using 5 µmol/L AMC- (Suc- Ala2- Pro- Phe) (Bachem) 
and calculated as U mg- 1 with purified chymotrypsin as internal 
standard and activities expressed in relation to faecal weight. MPO 
activity was measured as previously reported.38 Briefly, pancreatic 
tissue was homogenized on ice in a 20 mmol/L potassium phosphate 
buffer (pH 7.4) and centrifuged. The pellet was suspended in a buffer 
containing 50 mmol/L potassium phosphate (pH 6.0) and 0.5% ce-
tyltrimethylammonium bromide. MPO activity was measured using 
0.53 mmol/L O- dianisidine and 0.15 mmol/L H2O2 as substrates and 
SpectraMax Spectrophotometer (Molecular Devices). The results 
are calculated as fold change in comparison to unstimulated wild- 
type animals.
For measurement of cytokine secretion, splenocytes were stim-
ulated with 1 μg/mL LPS as reported 12,32,36 and activity in the su-
pernatants was quantified with the CBA mouse inflammation kit 
following the manufacturer's instructions (Becton Dickinson) and 
fluorescence activated cell sorting (FACS).
2.8 | Histology, immunohistochemistry and 
immunofluorescence staining of pancreatic tissues
Paraffin embedded tissues were sliced and stained with haematox-
ylin and eosin. For each animal, ten randomly chosen microscopic 
fields were investigated under a light microscope. For quantifica-
tion of oedema, necrosis and leucocyte infiltration, a modified his-
topathologic score adapted from Kyogoku et al 39 was used, that 
scored 0 for absent, 1 for less than 20%, 2 for 20%- 50% and 3 for 
more than 50% as previously described.40 Immunohistochemistry 
was performed from paraffin embedded tissue samples as previ-
ously reported. The following primary antibodies were used in a di-
lution of 1 to 200: anti- CFTR (Clone: A- 3, Santa Cruz Biotechnology, 
sc- 376683), p67- phox (Santa Cruz Biotechnology, sc- 374510) and 
anti- CD11b (abcam, ab133357). For immunofluorescence staining 
of CFTR snap- frozen tissue embedded with Tissue- Tek® OCTTM 
compound (Sakura Finetek, Alphen aan den Rijn) was cut into 1- to 
2- µm- thick slices, fixed with 20% acetone and washed with PBS. 
The anti- CFTR antibody (Clone: M3A7, DLN- 06996, Dianova) was 
used in a 1:100 dilution in 20% FCS, and incubation was performed 
over night at 4°C. An anti- rat IgG FITC- labelled antibody (Jackson 
ImmunoResearch) served as a secondary antibody. Nuclei were 
stained by DAPI and slides were mounted with DACO mounting me-
dium (Agilent Technologies Inc) for immunofluorescence.
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2.9 | Measurement of intracellular pH
Intracellular pH (pHi) was estimated using techniques as described 
before.41 Briefly, isolated ducts were bathed in standard HEPES so-
lution at 37°C and were loaded with the membrane- permeable ace-
toxymethyl derivative of BCECF (2 μmol/L) for 20- 30 minutes. After 
loading, the ducts were continuously perfused with solutions at a 
rate of 5- 6 mL/min. pHi was measured using a CellR imaging system. 
Four to seven regions of interest (ROIs) of 20- 28 cells in each intact 
duct were excited with light at wavelengths of 490 and 440 nm, and 
the 490/440 fluorescence emission ratio was measured at 535 nm.33
2.10 | Measurement of HCO3
-  secretion
We used the inhibitory stop method to determine the HCO3
-  ef-
flux across the luminal membrane: Basolateral Na+/HCO3
-  co- 
transporters, Cl- /HCO3
-  and Na+/H+ exchangers were blocked using 
H2DIDS (0.5 mmol/L) and amiloride (0.2 mmol/L) administered 
from the basolateral side of ductal cells for 5 minutes. The effects 
of H2DIDS and amiloride are likely to be confined to the basolateral 
transporters because a) H2DIDS is unlikely to gain rapid access to 
the lumen of the sealed ducts because of its charged sulphonic acid 
groups, and b) there are no amiloride- sensitive transporters at the 
F I G U R E  1   CFTR is aberrantly 
expressed in acinar cells of CFTRtm1HGU 
mice, but exocrine pancreatic function is 
maintained. (A) A transgenic mouse model 
containing a neomycin cassette and a part 
of exon 10 of the CFTR gene was used 
that has residual CFTR expression. (B) 
Immunofluorescence labelling of CFTR 
(Clone: M3A7, DLN- 06996, Dianova) in 
wild- type and CFTRtm1HGU mice showed 
a clear localization of CFTR on the 
cellular membrane in wild- types and a 
prominent labelling in the cytoplasm of 
CFTRtm1HGU mice. A second antibody 
(Clone: A- 3, Santa Cruz Biotechnology) 
was used for immunohistochemistry to 
verify the labelling. We confirmed the 
localization of CFTR at the cell membrane 
in wild- type mice, which was absent in 
CFTRtm1HGU animals. (C) Comparable stool 
chymotrypsin activities wild- type and 
CFTRtm1HGU mice indicate that exocrine 
pancreatic enzyme secretion is not 
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apical membrane of small interlobular ducts. The inhibition of baso-
lateral transporters caused a marked decrease in pHi. The rate of 
pHi acidification after H2DIDS and amiloride exposure reflects the 
intracellular buffering capacity and the rate at which HCO3
-  efflux 
is secreted across the luminal membrane via Cl- /HCO3
-  exchangers 
and possibly CFTR.42 The initial rate of intracellular acidification 
(dpH/dt) over the first 60 seconds starting from the administration 
of inhibitors was calculated by linear regression analysis using 60 
data points (one pHi measurement per second).
2.11 | Measurement of in vitro fluid secretion
Fluid secretion into the closed luminal space of the cultured ducts 
was analysed using a swelling method developed by Fernandez- 
Salazar et al43 Briefly, the ducts were transferred to a perfusion 
chamber and perfused with either standard HEPES or the HCO3
−/
CO2- buffered solution at 37°C. Bright- field images were ac-
quired at 1- min intervals using a CCD camera (CFW 1308C, Scion 
Corporation). Digital images of the ducts were analysed using Scion 
Image software (Scion Corp.) to obtain values for the area corre-
sponding to the luminal space in each image. Luminal area meas-
urements from individual images were normalized to the average 
of the first few in the series (A0) thus giving values for the relative 
area (AR = A/A0). These were then converted to relative volumes 
(VR = V/V0) by assuming that the lumen was cylindrical and by tak-
ing into account the relative increases in width and length in each 
series. Secretory rates were calculated from the rate of change of 
luminal volume and were normalized to the luminal epithelial sur-
face area. Secretory rate was expressed in picolitres per minute per 
square millimetre for the last 20 minutes of forskolin stimulation.
2.12 | Measurement of in vivo fluid secretion
Small animal magnetic resonance imaging (MRI) was used to de-
termine stimulated pancreatic fluid output as previously reported 
44 and wild- type controls compared to CFTRtm1HGU animals. 
Animals were allowed free access to pineapple juice 12 hours be-
fore the MRI examination. MRI was performed in a 7.1 Tesla ani-
mal scanner (Bruker). Strong T2- weighted series of the complete 
abdomen were acquired before and after retroorbital injection of 
10 IU units/kg body weight (b.w.) secretin (ChiroStim, ChiRhoClin, 
Burtonville, MD, United States). The time between injection and 
MRI was 6 min. The sequences were acquired using the image pa-
rameters: TR/TE 4400/83 ms; flip angle: 180°; matrix 256 × 256; 
field of view 40 × 40 mm; bandwidth 315 Hz/pixel; slice thick-
ness 1 mm; 20 slices. All image analyses were performed using 
Osirix (version 5; Pixameo, Bernex). In order to exclude effects 
of the basal secretion, MRI datasets before were subtracted from 
datasets after stimulation. The created images show the total 
excretion after secretin stimulation. Excreted fluid is defined as 
high signal intensity in created images. The fluid excretion into 
the small intestine was segmented in each slice. The software 
calculated the volume of the segmented areas as total excreted 
volume (TEV).
2.13 | Statistical analysis
The collected data are shown as means ± SEM from at least five 
animals per time point and group. Statistical analysis was performed 
by SigmaPlot (Systat Software GmbH, Erkrath, Germany) using the 
Students t- test for independent samples. The data from the pancre-
atic duct experiments were analysed by one- or two- way ANOVA 
tests.
3  | RESULTS
3.1 | Characterization of the CFTRtm1HGU mouse 
model
The insertion mutation (CFTRtm1HGU) between exons 9 and 10 
(Figure 1A) disrupts CFTR function but allows for significant 
amounts (median 37% of mRNA transcript) of alternatively spliced 
wild- type cftr mRNA to be transcribed. When we localized CFTR in 
the exocrine pancreas, we detected it as previously reported45 in 
duct cells as well as at the luminal membrane of acinar cells in wild- 
type animals (Figure 1B upper panel). In the untreated pancreas of 
CFTRRtm1HGU animals, the subcellular localization was identical, but 
a significant increase of fluorescent label was found in the cytosol of 
acinar cells, as opposed to being strictly confined to the cell mem-
brane (Figure 1B lower panel). The usage of a second anti- CFTR anti-
body (from Santa Cruz) confirmed these finding by immunochemistry 
and indicated a decreased membrane localization of the CFTR pro-
tein (Figure 1B antibody clone A- 3). To determine whether or not 
CFTR modification had affected the output of exocrine pancreatic 
enzymes, we compared the activity of chymotrypsin in stool pellets 
from CFTRRtm1HGU animals and wild- type littermates and found no 
significant difference (Figure 1C). This indicates that CFTRRtm1HGU 
mice have no exocrine pancreatic enzyme insufficiency.
3.2 | Increased severity of acute pancreatitis in 
CFTRtm1HGU mice
To investigate whether a modified CFTR expression alters disease 
severity, we induced acute pancreatitis in CFTRtm1HGU mice and 
corresponding wild- type animals by repeated intraperitoneal caer-
ulein injections. During the first 24 hours, the CFTR transgenic mice 
clearly developed a more severe disease course. In all animals, serum 
amylase, lipase as well as intrapancreatic trypsin activities increased 
after induction of pancreatitis. As previously shown,46 these enzyme 
activities showed a biphasic curve with peaks at one and 8 hours of 
which the first peak is thought to be induced by direct secretagogue 
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effects on acinar cells, whereas the second is thought to be mediated 
by activated inflammatory cells. Interestingly, only the later, second 
peaks were greater in CFTRtm1HGU animals when compared to their 
wild- type controls with pancreatitis, suggesting the direct response 
to supramaximal CCK stimulation of acinar cells did not differ from 
controls in the pancreas of CFTR- disrupted animals (Figure 2A- C). 
MPO activity, a surrogate marker for leucocyte infiltration, was 
higher in CFTRtm1HGU animals than in controls, and it peaked at 24h 
in the pancreas and at 8h in the lungs (Figure 2D&E).
On histology, the pancreas of CFTRtm1HGU mice clearly showed 
no signs of damage in the absence of caerulein stimulation, whereas 
all animals developed cellular vacuolization, interstitial oedema, 
tissue necrosis and inflammatory infiltrates in response to disease 
induction (Figure 3A). Tissue injury was clearly more prominent in 
CFTRtm1HGU animals and when we scored and quantitated the re-
sults for histology score, which was most pronounced 8h after dis-
ease onset of pancreatitis (Figure 3B). A detailed examination of 
individual parameters of the histology score showed a significant 
increase of inflammatory infiltrate and a trend towards increased 
oedema and necrosis at 8h in the CFTRtm1HGU mice (Figure 3C). 
Immunohistochemical stainings of macrophages by anti- CD11b 
(Figure 3D) and neutrophils by anti- p67- phox (Figure 3E) in pancre-
atic tissue samples indicated in both wild- type and CFTRtm1HGU ani-
mals that CD11b + macrophages represent the dominant infiltrating 
immune cell type, whereas p67- phox positive neutrophils 34 could 
only be detected sporadically. In CFTRtm1HGU animals there was a 
markedly stronger infiltration of CD11b + macrophages, which could 
explain the increased pancreatic damage.
3.3 | Premature intracellular zymogen 
activation and cell injury in CFTRtm1HGU mice
To test whether the absence of a greater disease severity after 
one hour of pancreatitis was due to an acinar cell- specific effect 
in CFTRtm1HGU mice, we isolated acini from the pancreas of CFTR- 
disrupted and wild- type animals and incubated them in parallel with 
CCK for up to 60 minutes.
F I G U R E  2   Acute pancreatitis has a more severe course in CFTRtm1HGU mice. (A and B) Acute pancreatitis was induced in wild- type and 
CFTRtm1HGU mouse strains by intraperitoneal injections of caerulein (8 x50 µg/kg bodyweight). Serum amylase and lipase activities were 
higher in CFTRtm1HGU mice only at 8h, but not after 1h, a time point directly affected by the pathological stimulation of acinar cells. (C) 
During acute pancreatitis, trypsin shows a typical biphasic curve of its activity after 1 and 8 h. There was no significant difference in activity 
between both groups at 1 h. However, at 8 h trypsin activity was increased in the transgenic mice. (D, E) Local infiltration of neutrophils into 
the pancreas and lungs was determined by measuring MPO activity in tissue homogenates. At 8 and 24 h after onset of the pancreatitis the 
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F I G U R E  3   Histological damage 
was increased in CFTR transgenic 
mice as shown by haematoxylin and 
eosin stainings (A). The calibration bar 
represents 100 µm. (A) Quantification 
of histological changes was performed 
by a separate evaluation of necrosis, 
inflammation and pancreatic oedema 
(B). Summed up, there was a significant 
increase of pancreatic damage at 8h 
after induction of pancreatitis in the 
CFTR transgenic animals, seen by a 
higher histology score (B). The single 
parameters showed a clear trend towards 
an increase but only the quantification 
of the infiltrating leucocytes reached 
significance 8h after the onset of the 
disease (C), and still showed a trend at 
24 h. A detailed analysis of infiltrating 
leucocytes by immunohistochemical 
staining of CD11b and p67- phox 
showed a prominent infiltration 
of CD11b + macrophages in both 
mice strains at 8h after induction of 
pancreatitis that was more predominant 
in the CFTRtm1HGU mice (D). In contrast to 
CD11b + macrophages, p67- phox- positive 
neutrophils could rarely be observed 
(E). At least five mice were used in every 
group. The experiments were performed 
in triplicates. Asterisks indicate significant 






F I G U R E  4   Premature intracellular 
zymogen activation and necrosis are 
similar in CFTR- mutant and wild- type 
mice. (A) Intracellular elastase activation 
in CFTRtm1HGU mice upon supramaximal 
CCK stimulation was equal to controls. (B) 
Cellular necrosis measured by inclusion 
of propidium iodide was not affected by 
the gene mutation. Data points show 
means ± SE of at least 5 experiments in 
each group and each time point
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Although both, wild- type and acini from CFTRtm1HGU mice, 
showed a rapid increase in intracellular protease activity 
(Figure 4A) and in acinar cell necrosis (Figure 4B) as indicated 
by increase propidium- iodine uptake, there was no significant 
difference between wild- type and CFTRtm1HGU animals upon 
CCK stimulation. This indicates that disruption of CFTR had no 
measurable effect on premature digestive enzyme activation or 
acinar cell injury and suggests that other mechanisms and cell 
types must account for the greater in vivo disease severity in 
CFTRtm1HGU mice.
3.4 | Duct cell function in CFTRtm1HGU mice
Previous studies have shown that a lack of CFTR in pancreatic duct 
cells leads to decreased bicarbonate secretion and impairs their 
physiological function.47,48 We therefore investigated the degree 
of duct cell impairment in CFTRtm1HGU mice by quantitating HCO3
-  
secretion using the inhibitory stop method. Exposing isolated ducts 
to 0.5 mmol/L H2DIDS and 0.2 mmol/L amiloride caused intracel-
lular acidosis due to inhibition of the basolateral Na+/HCO3
-  co- 
transporters and Na+/H+ exchangers 49 (Figure 5A). The summary 
F I G U R E  5   Changes in HCO3
-  and fluid secretion in pancreatic duct cells in CFTRtm1HGU and wild- type mice during acute pancreatitis. 
Intralobular pancreatic ducts were isolated 1 h after the last caerulein injection. The ducts were used for experiments after overnight 
incubation. (A) Representative intracellular pH (pHi) traces of pancreatic duct cells, demonstrating the effect of 0.2 mmol/L amiloride and 
0.5 mmol/L H2DIDS administered from the basolateral membrane in standard HCO3
- /CO2- buffered solution. (B) Summarized data for the 
dpH/dt changes that were calculated by linear regression analysis of pHi measurements made over the first 60 s after exposure of the 
transport inhibitors. (C) Wild- type animals clearly responded to forskolin stimulation by increased fluid secretion, but the CFTRtm1HGU 
animals did not. (D) The maximum of fluid secretion was significantly lower in CFTRtm1HGU compared to wild- type mice. Pancreatic ducts 
were prepared for at least from five mice per group and measurements were performed in triplicates. Asterisks indicate significant 
differences with P <.05
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of dpH/dt changes after addition of H2DIDS and amiloride in the 
different groups is displayed in Figure 5B. HCO3
-  secretion was 
significantly lower in mutant mice compared to wild- type controls. 
Secondly, changes of pHi were more overt in ducts from acute pan-
creatitis animals than from controls but ultimately similar between 
groups. In the next step, fluid secretion of interlobular pancreatic 
ducts was determined by using video microscopy to measure the 
rate of swelling of isolated duct segments that had sealed follow-
ing overnight culture. Initially, ducts were perfused with standard 
HEPES- buffered solution and then perfusion was switched to stand-
ard HCO3
−/CO2- buffered solution. Ducts were stimulated with 
5 μmol/L forskolin from 10 minutes thereafter. Stimulation of the 
WT ducts with 5 μmol/L forskolin caused a dynamic swelling of the 
ducts (Figure 4C) as a result of fluid secretion into the closed luminal 
space. The secretory rate, calculated from the rate of change in lumi-
nal volume, was 211 ± 58 pl/min/mm2 after stimulation. In contrast, 
ducts from TG mice did not show increased secretion in response to 
forskolin (Figure 5C). The secretory rate was 31 ± 74 pL/min/mm2, 
which represents a reduction of 85% compared with the WT con-
trols. The summary of fluid secretion data is shown in Figure 5D. The 
maximal changes of relative luminal volume are significantly reduced 
in mutant mice compared to wild- type controls.
To test whether this impairment translates to the in vivo 
situation, we used Magnetic Resonance Imaging (Figure 6A) of 
mice stimulated with secretin and found a prominent decrease 
in fluid secretion in the CFTRtm1HGU mice, which was reduced 
to one fifth of that in wild- type controls (Figure 6B). These data 
demonstrate a strong impairment of pancreatic duct cell function 
in CFTRtm1HGU mice, which differed greatly from the effects on 
acinar cells.
3.5 | Impairment of leucocyte function in 
CFTRtm1HGU mice
The differences between CFTRtm1HGU and wild- type mice in terms 
of serum pancreatic enzyme and intrapancreatic trypsin activities 
in the later (rather than the early) disease course of pancreatitis, as 
well as the differences in MPO activity in the lungs and pancreas 
of the animals, suggested that the effects of the CFTR transgene 
are ultimately connected to infiltrating inflammatory cells. These 
findings prompted us to analyse the response of immune cells 
from CFTRtm1HGU animals directly. When we stimulated isolated 
splenocytes with lipopolysaccharide (LPS) and measured the cy-
tokine release, we detected a significantly increased secretion of 
the pro- inflammatory cytokines TNF- α, IFN- γ and IL- 6 in spleno-
cytes of the transgenic mice (Figure 7A- C). On the other hand, the 
anti- inflammatory cytokine IL- 10 was found to be reduced in the 
transgenic animals (Figure 7D). This combination of an increased 
pro- inflammatory cytokine secretion along with a decreased anti- 
inflammatory chemokine release could represent an additional ex-
planation for greater disease severity in CFTRtm1HGU mice.
F I G U R E  6   Fluid secretion after 
secretin stimulation in magnetic 
resonance cholangiopancreatography 
(MRCP). Fluid volume was markedly 
reduced in CFTRtm1HGU compared to 
wild- type mice after secretin stimulation 
(A + B)
A B
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4  | DISCUSSION
Mutations in the CFTR gene lead to a defective CFTR channel pro-
tein, a major regulator of the transcellular transport of chloride and 
bicarbonate. CFTR mutations were originally identified in patients 
with cystic fibrosis (CF), but later they were also found to be as-
sociated with male vas deference infertility and chronic or recurrent 
pancreatitis. CF is perhaps the best investigated genetic disorder 
and most frequently based on a loss of the amino acid phenylalanine 
in codon 508 (delF508), either on both alleles or in combination with 
other variants of the cftr- gene.15 CF patients often show a very vari-
able clinical course including pulmonary complications such as bron-
chiectasis, increased mucus production and chronic endobronchial 
inflammation but also an impairment of other organs that include 
the reproductive system leading to infertility, the liver with abnor-
mal liver function and cirrhosis, and the pancreas with exocrine and 
endocrine insufficiency.50 The variable extent of pancreatitis that 
develops in patients with CFTR mutations16- 18 is quite distinct from 
the exocrine pancreatic insufficiency that develops in CF patients 
and typically arises in subjects without overt impairment of pul-
monary function and with preserved exocrine pancreatic function. 
Sometimes the difference is not quite clear- cut and subjects who 
initially presented with pancreatitis alone can still develop pulmo-
nary dysfunction later in life and may have to be reclassified as mild 
cases of CF.51 Whether the pancreatitis- only phenotype is due to 
mutations (or compound heterozygous combinations of mutations) 
that confer a milder defect in CFTR function or whether pleotropic 
and modifier effects determine the pancreatitis phenotype is still 
being debated.23 Some attempts have been made to elucidate the 
underlying mechanism of pancreatitis under impairment of the 
CFTR experimentally. They either used mice with complete deletion 
of the cftr- gene 24 or transgenic animals carrying the most common 
deletion mutant found in humans with CF.25 The acinar cell defects 
identified in these animals included trafficking defects of zymogen 
granule membranes from the lumen,52 not unlike those found in 
models of biliary pancreatitis,53 solubilization of secretory (pro)en-
zymes, dilatation of the acinar lumen, a reduction in zymogen gran-
ules and persistent aggregation of secretory enzymes released into 
the luminal space. Another study found greater acinar cell injury in 
response to supraphysiological stimulation, a more severe inflam-
matory response and, most prominently, reduced apoptosis.26 Some 
of these effects are clearly consistent with pancreatitis und are 
compatible with pancreatic manifestation of CF.
To experimentally create a situation that mimics the human sit-
uation of pancreatitis in the presence of preserved residual CFTR 
function and pancreatic sufficiency more closely, we used a pre-
viously reported strain of mice (CFTRtm1HGU).28 These mice have 
a normal life expectancy and no obvious pancreas phenotype,27 
which we confirmed by a regular pancreatic microanatomy in un-
treated transgenic animals. Moreover, exocrine pancreatic function, 
as determined by faecal excretion of chymotrypsin, was also found 
to be unimpaired, whereas it is known to be defective in other ge-
netic disorders of the pancreas.37 At early time intervals of pancre-
atitis, which are considered hallmarks of acinar cell damage induced 
by the secretagogue, we found that serum pancreatic enzymes 
and intrapancreatic trypsinogen activation did not differ between 
CFTRtm1HGU and wild- type controls. When we tried to reproduce this 
effect (or better the absence of this acinar cell effect) in isolated 
acini ex vivo, we again found no difference in the response to injury 
between the CFTRtm1HGU and control mice.
F I G U R E  7   Pro- inflammatory 
alterations of the immune system in 
isolated and LPS stimulated splenocytes 
of CTFR- mutant mice. (A- C) An elevated 
secretion of TNFα, INF- γ and IL6 was 
found, whereas (D) release of the anti- 
inflammatory IL- 10 was lower in the 
supernatant of splenocytes derived from 
transgenic animals. Splenocytes were 
isolated from at least five mice per group 
and measurements were performed in 
triplicates. Data points show means ± SE 
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Yet, pancreatitis in vivo was clearly more severe in terms of his-
tological overall damage to the pancreas and specifically in terms of 
leucocyte infiltration of the pancreas and lungs.
One part of the organ that has clearly moved into the focus of 
pancreatitis researchers11 as well as the CFTR community54 is the 
pancreatic duct. Here, our data were much more consistent with 
the impairment of bicarbonate and fluid secretion as well as pHi 
regulation as it would be expected from a modification in CFTR 
gene affecting function. All were found to be significantly impaired 
in isolated pancreatic ducts as well as in vivo on MRI- imaging and 
fluid quantitation. In the absence of an immediate or direct aci-
nar cell effect, this finding readily explains the greater severity of 
pancreatitis.
A third reason of greater severity would be a change in inflam-
matory cell function. Duct occluding neutrophils and their extra-
cellular traps,14 inflammatory cells cleaving the junctions between 
acinar cells 7,13,34 or directly inducing digestive protease activation 
by releasing TNFα36 are well- established mechanisms of pancreati-
tis induction. The majority of infiltrating cells are CD11b + macro-
phages, which is a clear sign of a greater severity, because infiltrating 
macrophages directly correlate with the disease severity and local 
pancreatic damage 32,36 as well as systemic immune response.12 
Macrophages phagocytose necrotic cells and polarize into a pro- 
inflammatory M1- like phenotype, leading to a massive release of 
pro- inflammatory cytokines such as IL- 1β, IL- 6, IL- 18 and TNFα, 
which contribute to local and systemic injury.12 Mutations in CFTR 
have also been reported to mediate effects on cells of the immune 
system.55,56 When we found the infiltration of immune cells into 
the lungs and pancreas during pancreatitis to be a most prominent 
feature of greater severity in the CFTRtm1HGU animals, we investi-
gated whether the same effect could be reproduced ex vivo in iso-
lated splenocytes. Here, we found that LPS stimulation resulted in 
an increased release of pro- inflammatory INFγ, IL- 6 and TNFα and a 
reduced release of the anti- inflammatory IL- 10 into the supernatant. 
These observations are in line with results from other groups who 
found an increased release of pro- inflammatory cytokines in CFTR- 
deleted or downregulated epithelial cells, mediated by increased 
p65/NFκB activation,57 which also plays an important role in pancre-
atic acinar cells 58 and infiltrating macrophages.32 This observation 
clearly indicates that CFTR mutations, even those that leave acinar 
cells in experimental pancreatitis unaffected, may have a significant 
effect on the immune system. This may also have contributed to the 
greater severity of pancreatitis. Whether the altered immune re-
sponse of CFTRtm1HGU mice is a direct effect of CFTR impairment 
in the cell membrane of immune cells or, rather, an indirect effect 
mediated by tissue- resident immune cells in organs such as the in-
testine, which are, unlike the exocrine pancreas, directly affected 
by the CFTRtm1HGU transgene,27 cannot be answered conclusively at 
this point.
In conclusion, our results confirm that impairment of CFTR 
function increases the susceptibility of the pancreas towards exog-
enous injury and clearly renders the disease course of acute pan-
creatitis more severe. In an experimental model in which sufficient 
residual CFTR function is maintained and animals have not devel-
oped exocrine pancreatic insufficiency, the underlying mechanisms 
appear to involve duct cells and the immune system, whereas 
acinar cells are not the source but a target of the CFTR pancreas 
phenotype.
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